Amyotrophic Lateral Sclerosis: An Update for 2018-Reference-Cited by-同舟云学术

Amyotrophic Lateral Sclerosis: An Update for 2018

Published:2018-11 Issue:11 Volume:93 Page:1617-1628
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Oskarsson Björn,Gendron Tania F.,Staff Nathan P.

Publisher

Elsevier BV

Subject

General Medicine

Reference113 articles.

1. Deux cas d'atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere;Charcot;Arch Physiol Neurol Pathol,1869

2. Prevalence of amyotrophic lateral sclerosis—United States, 2012-2013;Mehta;MMWR Surveill Summ,2016

3. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998;Sorenson;Neurology,2002

4. The epidemiology of ALS: a conspiracy of genes, environment and time;Al-Chalabi;Nat Rev Neurol,2013

5. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS;DeJesus-Hernandez;Neuron,2011

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuro-regeneration or Repair: Cell Therapy of Neurological Disorders as A Way Forward;Current Neuropharmacology;2024-12

2. Nurturing hope: Uncovering the potential of herbal remedies against amyotrophic lateral sclerosis;PharmaNutrition;2024-09

3. Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2024-08-27

4. The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis;Heliyon;2024-08

5. Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety;Neural Regeneration Research;2024-07-10